Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
TGF-beta activated kinase 1 (MAP3K7) binding protein 2 | 0.617 | 0.654 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
BSCL2 lipid droplet biogenesis associated, seipin | 0.545 | 0.692 | 1.1E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
X-linked Kx blood group | 0.575 | 0.654 | 0.95 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
caveolae associated protein 1 | 0.559 | 0.654 | 5.0E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
DNA polymerase gamma, catalytic subunit | 0.457 | 0.846 | 2.1E-09 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
DNA polymerase gamma 2, accessory subunit | 0.558 | 0.769 | 1.5E-10 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
dystrobrevin alpha | 0.695 | 0.385 | 0.63 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
1-acylglycerol-3-phosphate O-acyltransferase 2 | 0.585 | 0.654 | 1.2E-07 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
twinkle mtDNA helicase | 0.516 | 0.692 | 3.2E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 0.641 | 0.500 | 1.00 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
transmembrane protein 43 | 0.653 | 0.462 | 1.2E-12 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
ribonucleotide reductase regulatory TP53 inducible subunit M2B | 0.527 | 0.769 | 2.4E-03 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
TNNI3 interacting kinase | 0.691 | 0.346 | 3.1E-48 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
Fos proto-oncogene, AP-1 transcription factor subunit | 0.411 | 0.885 | 0.26 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
solute carrier family 25 member 4 | 0.568 | 0.692 | 0.45 |
|
disease | 0.100 | None | 0 | 0 | |||||||||||
|
coagulation factor III, tissue factor | 0.415 | 0.846 | 1.9E-02 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 1989 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 4 | 0.610 | 0.615 | 2.5E-02 |
|
disease | 0.320 | None | 1.000 | 3 | 0 | 1994 | 2007 | ||||||||
|
potassium voltage-gated channel subfamily Q member 1 | 0.485 | 0.769 | 4.5E-08 |
|
disease | 0.200 | None | 1.000 | 36 | 9 | 1999 | 2020 | ||||||||
|
natriuretic peptide B | 0.513 | 0.808 | 9.9E-06 |
|
disease | 0.370 | None | 1.000 | 8 | 0 | 1999 | 2019 | ||||||||
|
phospholamban | 0.595 | 0.577 | 0.45 |
|
disease | 0.450 | None | 1.000 | 6 | 0 | 1999 | 2019 | ||||||||
|
major histocompatibility complex, class I, C | 0.415 | 0.846 | 1.6E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
solute carrier family 24 member 3 | 0.700 | 0.423 | 0.88 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
disease | 0.100 | None | 1.000 | 33 | 1 | 2000 | 2020 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.400 | None | 0.970 | 33 | 2 | 2000 | 2020 | ||||||||
|
angiotensin II receptor type 1 | 0.423 | 0.846 | 5.3E-04 |
|
disease | 0.060 | None | 0.833 | 6 | 4 | 2000 | 2019 |